Lazard Asset Management LLC trimmed its stake in Stericycle Inc (NASDAQ:SRCL) by 3.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 973,254 shares of the business services provider’s stock after selling 29,594 shares during the period. Lazard Asset Management LLC’s holdings in Stericycle were worth $52,964,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. JOYN Advisors Inc. boosted its position in Stericycle by 1,253.7% during the fourth quarter. JOYN Advisors Inc. now owns 731 shares of the business services provider’s stock valued at $27,000 after acquiring an additional 677 shares during the last quarter. Bronfman E.L. Rothschild L.P. boosted its position in Stericycle by 159.5% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 807 shares of the business services provider’s stock valued at $30,000 after acquiring an additional 496 shares during the last quarter. Pearl River Capital LLC bought a new stake in Stericycle during the fourth quarter valued at $41,000. Oregon Public Employees Retirement Fund boosted its position in Stericycle by 6,998.9% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,638,209 shares of the business services provider’s stock valued at $45,000 after acquiring an additional 1,615,132 shares during the last quarter. Finally, Blue Sky Asset Management LLC bought a new stake in Stericycle during the first quarter valued at $60,000. Institutional investors and hedge funds own 96.52% of the company’s stock.
A number of analysts have commented on SRCL shares. BMO Capital Markets upped their price target on shares of Stericycle from $41.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, March 4th. Robert W. Baird cut shares of Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 price target on the stock. in a research report on Wednesday, April 17th. Zacks Investment Research cut shares of Stericycle from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 7th. BidaskClub cut shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Tuesday. Finally, Barrington Research cut their price target on shares of Stericycle from $64.00 to $55.00 and set an “outperform” rating on the stock in a research report on Monday, March 11th. Five investment analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $59.00.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, May 2nd. The business services provider reported $0.57 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.87 by ($0.30). The company had revenue of $830.10 million for the quarter, compared to the consensus estimate of $866.19 million. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%. Stericycle’s revenue for the quarter was down 7.3% compared to the same quarter last year. During the same period last year, the company earned $1.21 EPS. On average, analysts anticipate that Stericycle Inc will post 3.34 earnings per share for the current fiscal year.
In other news, Director Mark C. Miller sold 260,314 shares of the stock in a transaction dated Tuesday, April 9th. The shares were sold at an average price of $57.18, for a total transaction of $14,884,754.52. Following the transaction, the director now owns 325,848 shares of the company’s stock, valued at approximately $18,631,988.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.30% of the stock is owned by corporate insiders.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Recommended Story: Trade Deficit
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.